Med Gen Initiates Distribution into Ireland with Alliance UniChem International Trading(R).

BOCA RATON, Fla. -- Med Gen Inc. (OTCBB:MGEN), manufacturers of the national brands UNDIET(TM) spray weight loss system, Snorenz(R), snore relief throat spray, Painenz(R), roll on pain relief formula, and Good Nights Sleep(R), sleep aid throat spray, announced today that it has received an initial order for both SnorAway(R), snoring relief formula and Painenz(R), roll on arthritic pain relief formula for Ireland from its new distributor, Alliance UniChem International Trading(R) (AUIT).

AUIT is considered one of the largest distributors of both prescription and OTC drugs in Europe. The Distribution Agreement covers all products now being manufactured by Med Gen. Paul Kravitz, Chairman and Chief Executive, commented in a morning interview, that the Distribution Agreement with AUIT is a watershed achievement for Med Gen. "Our new relationship with AUIT will open significant distribution channels in all EU countries. AUIT controls a significant market overseas and Med Gen expects to build market share quickly because of this relationship."

Ireland is the first country to receive Med Gen products from AUIT and the company expects that it will be followed up over the next few months with orders on a country-by-country basis. Under the Agreement, AUIT will control all marketing and placement of products using Med Gen brand names as they exist now in the United States except for Snorenz(R), which is branded SnorAway(R) in most international markets. As reported earlier, Snorenz(R) is just now arriving in New Zealand under a private label.

Acceptance of our products in foreign markets requires patience and flexibility since government approval is necessary. In January we announced our commitment to build this business and, although it has been difficult at times, we are now showing major strides in achieving our goals. One such major achievement is this new relationship with AUIT.

About Med Gen Inc.

Med Gen Inc., in business since 1996, manufactures and markets the world's first liquid spray snoring relief formula, Snorenz(R) for which its founders received a patent in 1998. Since its existence, Med Gen has continued to develop its "sprays the way" technology, introducing numerous other products that deal with large market health issues. All products are nationally advertised and marketed to major chain and drug stores as well as direct sales via the company web site, TV and Radio.

The company has begun its test marketing of a radically different approach and delivery system for a weight loss system, UNDIET(TM). IRI, a retail data reporting service, suggests that the combined market for snoring and sleep aides could exceed $500 million and the weight loss market could exceed $70 billion by 2007.

For further information on Med Gen Inc., please visit http://www.medgen.com or call 1-800-521-9311.

This Press Release contains or incorporates by reference "forward looking statements" including certain information with respect to plans and strategies of Med Gen Inc. For this purpose, any statements contained herein or incorporated herein by references that are not statements of historical fact may be deemed forward looking statements. Without limiting the foregoing, the words "believes", "suggests", "anticipates", "plans", "expects", and similar expressions are intended to identify forward looking statements. There are a number of events or actual results of Med Gen operations that could differ materially from those indicated by such forward looking statements.

Med Gen, Inc. is a publicly traded company on the OTCBB exchange "MGEN".